NCT05068349View on ClinicalTrials.gov

For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.

PHASE4RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 7, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
StrokeCerebral InfarctionBrain InfarctionBrain IschemiaNervous System DiseasesCentral Nervous System DiseasesVascular Diseases
Interventions
DRUG

Butylphthalide

Butylphthalide sodium chloride injection 25mg, 2 times a day, 7-14 days, followed by 0.2g butylphthalide soft capsules, 3 times a day, 76-83 days, a total of 90 days.

Trial Locations (1)

Unknown

RECRUITING

Shandong Provincial Qianfoshan Hospital, Jinan

All Listed Sponsors
lead

Qianfoshan Hospital

OTHER